Atlas Trials

Evaluate the Precision of ABL-101 Perfluorocarbon and Fluorine-19 MRI for the Mapping of Atherosclerotic Plaque Composition and Inflammation in Patients Undergoing Carotid Endarterectomy

Clinical trial NCT06850324 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06850324
Sponsor
Ruud van Heeswijk
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Atherosclerotic Disease, CarotidCarotid Endarterectomy
Start date
2025-07-01
Primary completion
2027-06-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.